BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Kidney tumors AND ETV6, TEL/ABL, 2120, ENSG00000139083, P41212, TEL
55 results:

  • 1. Report and follow-up on two new patients with congenital mesoblastic nephroma.
    Serra G; Cimador M; Giuffrè M; Insinga V; Montante C; Pensabene M; Piro E; Salerno S; Schierz IAM; Corsello G
    Ital J Pediatr; 2023 Sep; 49(1):124. PubMed ID: 37726782
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Neurotrophic tropomyosin receptor kinase (NTRK) fusion positive tumors: a historical cohort analysis.
    Lemelle L; Guillemot D; Hermann AL; Gauthier A; Carton M; Corradini N; Rome A; Berlanga P; Jourdain A; Marie Cardine A; Jannier S; Boutroux H; Defachelles AS; Aerts I; Geoerger B; Karanian M; Doz F; Brisse HJ; Schleiermacher G; Delattre O; Pierron G; Orbach D
    Expert Rev Anticancer Ther; 2023; 23(8):865-874. PubMed ID: 37434345
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Congenital mesoblastic nephroma: review of current management and outcomes in a single centre.
    Rayner J; Vinycomb T; Wanaguru D; Jiwane A
    ANZ J Surg; 2023 Apr; 93(4):1008-1011. PubMed ID: 36382605
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. A novel etv6-NTRK3 gene fusion in primary renal fibrosarcoma.
    Jiang H
    Eur Rev Med Pharmacol Sci; 2022 Jul; 26(13):4705-4708. PubMed ID: 35856362
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Infantile fibrosarcoma with an EGFR kinase domain duplication: Underlining a close relationship with congenital mesoblastic nephroma and highlighting a similar morphological spectrum.
    van Spronsen R; Kester LA; Knops RRG; van de Sande MAJ; van Leenders GJLH; de Laat PCJ; Stortelder E; Korpershoek E; van Noesel MM; Meister MT; Koerkamp MJAG; de Graaf N; Giovannoni I; Tops BBJ; de Krijger RR; Ter Horst SAJ; Flucke U; Alaggio R; Hiemcke-Jiwa LS
    Ann Diagn Pathol; 2022 Apr; 57():151885. PubMed ID: 35032896
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Mesenchymal neoplasms with NTRK and other kinase gene alterations.
    Davis JL; Al-Ibraheemi A; Rudzinski ER; Surrey LF
    Histopathology; 2022 Jan; 80(1):4-18. PubMed ID: 34958503
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. telmisartan-Induced Cytotoxicity via G
    Tsujiya Y; Hasegawa A; Yamamori M; Okamura N
    Biol Pharm Bull; 2021; 44(12):1878-1885. PubMed ID: 34853271
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. NTRK-Rearranged soft tissue neoplasms: A review of evolving diagnostic entities and algorithmic detection methods.
    Surrey LF; Davis JL
    Cancer Genet; 2022 Jan; 260-261():6-13. PubMed ID: 34794069
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Chemotherapy for Muscle-invasive Bladder Cancer: Impact of Cisplatin Delivery on Renal Function and Local Control Rate in the Randomized Phase III VESPER (GETUG-AFU V05) Trial.
    Culine S; Harter V; Gravis G; Fléchon A; Chevreau C; Mahammedi H; Laguerre B; Guillot A; Joly F; Abadie-Lacourtoisie S; Geoffrois L; Fiore FD; Roubaud G; Barthélémy P; Voog E; Emambux S; Serrate C; Saldana C; Nguyen-Tan-Hon T; Loriot Y; Eymard JC; Huillard O; Rolland F; Houédé N; Spano JP; Demery ME; Vieillot S; L'Haridon T; Hilgers W; Allory Y; Pfister C;
    Clin Genitourin Cancer; 2021 Dec; 19(6):554-562. PubMed ID: 34602349
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. An unusual fusion gene EML4-ALK in a patient with congenital mesoblastic nephroma.
    Misove A; Vicha A; Zapotocky M; Malis J; Balko J; Nemeckova T; Szabova J; Kyncl M; Novakova-Kodetova D; Stolova L; Jencova P; Broz P; Krskova L
    Genes Chromosomes Cancer; 2021 Dec; 60(12):837-840. PubMed ID: 34378283
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Second Report of
    Hughes CE; Correa H; Benedetti DJ; Smith B; Sumegi J; Bridge J
    Pediatr Dev Pathol; 2021; 24(6):554-558. PubMed ID: 34120511
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Novel BRAF gene fusions and activating point mutations in spindle cell sarcomas with histologic overlap with infantile fibrosarcoma.
    Penning AJ; Al-Ibraheemi A; Michal M; Larsen BT; Cho SJ; Lockwood CM; Paulson VA; Liu YJ; Plank L; Fritchie K; Beadling C; Neff TL; Corless CL; Rudzinski ER; Davis JL
    Mod Pathol; 2021 Aug; 34(8):1530-1540. PubMed ID: 33850302
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Pediatric Renal tumors: Updates in the Molecular Era.
    Treece AL
    Surg Pathol Clin; 2020 Dec; 13(4):695-718. PubMed ID: 33183728
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Adjuvant Maintenance Larotrectinib Therapy in 2 Children With NTRK Fusion-positive High-grade Cancers.
    Carter-Febres M; Schneller N; Fair D; Solomon D; Perry A; Roy A; Linscott L; Alashari M; Kestle JR; Bruggers CS
    J Pediatr Hematol Oncol; 2021 Oct; 43(7):e987-e990. PubMed ID: 33093355
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. telmisartan Exacerbates Cisplatin-Induced Nephrotoxicity in a Mouse Model.
    Hosoda A; Matsumoto Y; Toriyama Y; Tsuji T; Yoshida Y; Masamichi S; Kohno T
    Biol Pharm Bull; 2020; 43(9):1331-1337. PubMed ID: 32879207
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. [Clinicopathological characteristics of NTRK-rearranged mesenchymal tumors in childhood].
    Yin MZ; Ma J; He Q; Shen P; Chen JF; Jin XT; Zhang ZD; Kuick CH; Chen HY; Ng EHQ; Aw SJ; Chang KTE
    Zhonghua Bing Li Xue Za Zhi; 2020 Jul; 49(7):675-680. PubMed ID: 32610377
    [No Abstract]    [Full Text] [Related]  

  • 17. Congenital mesoblastic nephroma is characterised by kinase mutations including EGFR internal tandem duplications, the etv6-NTRK3 fusion, and the rare KLHL7-BRAF fusion.
    Zhao M; Yin M; Kuick CH; Chen H; Aw SJ; Merchant K; Ng EHQ; Gunaratne S; Loh AHP; Gu W; Tang H; Chang KTE
    Histopathology; 2020 Oct; 77(4):611-621. PubMed ID: 32590884
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Unusual Case of Concurrent Retroperitoneal Congenital Infantile Fibrosarcoma and Cellular Type Congenital Mesoblastic Nephroma.
    Monsereenusorn C; Supakul N; Satayasoontorn K; Traivaree C; Rujkijyanont P
    J Pediatr Hematol Oncol; 2020 Nov; 42(8):e801-e806. PubMed ID: 31343481
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Modification of American Joint Committee on cancer prognostic groups for renal cell carcinoma.
    Shao N; Wang HK; Zhu Y; Ye DW
    Cancer Med; 2018 Nov; 7(11):5431-5438. PubMed ID: 30306741
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Radiogenomics of Clear Cell Renal Cell Carcinoma: Associations Between mRNA-Based Subtyping and CT Imaging Features.
    Bowen L; Xiaojing L
    Acad Radiol; 2019 May; 26(5):e32-e37. PubMed ID: 30064916
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 3.